TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

CSL BEHRING LLC

RespiratoryImmunologyNeurology
Biotech

CSL BEHRING LLC is a biotechnology company focused on Respiratory, Immunology, Neurology.

2025
Since
1
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

ANDEMBRY 2025-06-16
Type 1 - New Molecular Entity
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Respiratory 67%
0 drugs Phase 3: 1 Phase 2: 2 Phase 1: 2
Immunology 20%
0 drugs Phase 1: 3
Neurology 7%
0 drugs Phase 1: 1
Cardiovascular 7%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Novartis big-pharma
Cardiovascular, Immunology, Respiratory
GSK big-pharma
Respiratory, Immunology, Neurology
Roche big-pharma
Neurology, Immunology, Respiratory
AstraZeneca big-pharma
Respiratory, Cardiovascular, Immunology
Boehringer Ingelheim big-pharma
Respiratory, Immunology, Cardiovascular